Therapy of relapsed or refractory low-grade follicular lymphomas: Factors associated with complete remission, survival and time to treatment failure

J. A. Spinolo, F. Cabanillas, D. O. Dixon, S. M. Khorana, P. Mclaughlin, W. S. Velasquez, F. B. Hagemeister, J. R. Redman, F. Swan

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Patients with relapsed low-grade follicular lymphomas (LGFL) frequently respond to subsequent therapy and can have long survival, but are rarely cured. Factors associated with complete remission (CR) rate, length of survival, and time to treatment failure (TTF) after relapse are not well known. We assessed such factors by multivariate analysis in a retrospective review of 95 patients with relapsed LGFL treated with investigational chemotherapy regimens at our institution. The CR rate after therapy was 22%; the likelihood of achieving CR was inversely associated with the number of previous treatment failures (P < 0.001) and serum.

Original languageEnglish (US)
Pages (from-to)227-232
Number of pages6
JournalAnnals of Oncology
Volume3
Issue number3
DOIs
StatePublished - Mar 1992

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Therapy of relapsed or refractory low-grade follicular lymphomas: Factors associated with complete remission, survival and time to treatment failure'. Together they form a unique fingerprint.

Cite this